Analyst initiations 3-19-07: CVS Corp reinstated at JP Morgan & Credit Suisse
Posted Mar 19th 2007 11:31AM by Kevin Shult
Filed under: Before the Bell, CVS Corp (CVS), Analyst Initiations
MOST NOTEWORTHY: CVS Corp (CVS), Express Scripts, Inc (ESRX) and Goodrich Petroleum Corp (GDP) were some of today's more notable initiations:
- CVS Corp (NYSE: CVS) was reinstated at Credit Suisse with an Outperform and at JP Morgan with Neutral ratings.
- Express Scripts (NASDAQ: ESRX) was reinstated at Credit Suisse with an Outperform rating, up from its Neutral rating, and resumed at Bank of America with a Buy rating. JP Morgan reinstated Express Scripts share with an Overweight rating.
- Goodrich Petroleum (NYSE: GDP) was initiated with an Overweight rating at JP Morgan.
OTHER INITIATIONS:
- Jefferies initiated Cellcom Israel Ltd (NYSE: CEL) with a Buy rating and $21 target.
- CIBC initiated 3SBio Inc (NASDAQ: SSRX) with a Sector Outperformer rating and $17 target; the firm said 3SBio Inc offers the broadest range of BioGenerics in the Chinese market and views the company as an execution story and country play.
- Cowen started G-III Apparel Group, Ltd (NASDAQ: GIII) with an Outperform rating based on expectations of market share growth to be driven by new brands and products.
- BMO Capital Markets expects Riverbed Technology, Inc (NASDAQ: RVBD) with a Market Perform rating.
- Lazard started Synta Pharmaceuticals Corp (NASDAQ: SNTA) with a Buy rating; Bear Stearns initiated shares of Synta with an Outperform rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: 3SBio, analyst, cel, cellcom, cvs, esrx, express scripts, ExpressScripts, g-111, gdp, giii, goodrich petro, GoodrichPetro, initiation, rating, riverbed, rvbd, snta, ssrx, synta, theflyonthewall.com
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
